Fundamentals screen · refreshed after the Nov 12, 2026 close
Net-cash companies: Healthcare
Companies whose cash and investments exceed all debt by at least a quarter of their market value. Net cash is cash plus short-term investments minus debt, from the latest quarterly balance sheet.
| # | Company | Price | Net cash | Mkt cap | Revenue YoY | P/E |
|---|---|---|---|---|---|---|
| 1 | EIKNEikon TherapeuticsHealthcare | $6.04 | $531.2M | $327.2M | — | — |
| 2 | JANXJanux TherapeuticsHealthcare | $11.50 | $945.7M | $703.3M | −7.1% | — |
| 3 | ARVNArvinasHealthcare | $6.87 | $558.2M | $449.9M | −98.8% | — |
| 4 | ALTAltimmuneHealthcare | $1.61 | $291.5M | $313.2M | −100.0% | — |
| 5 | AVTXAvalo TherapeuticsHealthcare | $7.70 | $393.0M | $445.2M | — | — |
| 6 | CTMXCytomX TherapeuticsHealthcare | $2.04 | $348.0M | $444.7M | −71.7% | — |
| 7 | ASMBAssembly BiosciencesHealthcare | $20.18 | $320.4M | $410.9M | +38.9% | — |
| 8 | MPLTMapLight TherapeuticsHealthcare | $7.07 | $304.7M | $392.9M | — | — |
| 9 | NGNENeurogeneHealthcare | $23.90 | $359.7M | $494.8M | — | — |
| 10 | GLUEMonte Rosa TherapeuticsHealthcare | $9.31 | $577.7M | $795.5M | +325.8% | — |
| 11 | KURAKura OncologyHealthcare | $7.43 | $482.3M | $682.7M | +10.1% | — |
| 12 | OLMAOlema PharmaceuticalsHealthcare | $7.52 | $458.1M | $658.8M | — | — |
| 13 | WVEWave Life SciencesHealthcare | $3.16 | $430.7M | $622.3M | +72.9% | — |
| 14 | CRMDCorMedixHealthcare | $4.84 | $256.7M | $384.7M | +156.5% | 2.1× |
| 15 | BCAXBicara TherapeuticsHealthcare | $10.11 | $442.3M | $671.2M | — | — |
| 16 | PRTAProthenaHealthcare | $8.23 | $271.4M | $422.6M | −74.3% | — |
| 17 | CTNMContineum TherapeuticsHealthcare | $9.78 | $244.5M | $384.0M | — | — |
| 18 | ALMSAlumisHealthcare | $6.13 | $502.3M | $793.4M | −37.7% | — |
| 19 | NRIXNurix TherapeuticsHealthcare | $15.60 | $1.05B | $1.70B | +8426.3% | 5.8× |
| 20 | CRONCronos Group Inc. Common ShareHealthcare | $3.41 | $741.2M | $1.25B | +71.8% | 21.6× |
| 21 | AVBPArriVent BioPharmaHealthcare | $13.07 | $393.2M | $676.0M | — | — |
| 22 | ENTAEnanta PharmaceuticalsHealthcare | $11.20 | $189.5M | $326.2M | −21.6% | — |
| 23 | AKTSAktis OncologyHealthcare | $16.28 | $517.3M | $905.5M | — | — |
| 24 | TECXTectonic TherapeuticHealthcare | $21.04 | $234.6M | $411.3M | — | — |
| 25 | BNTCBenitec BiopharmaHealthcare | $9.09 | $180.0M | $317.1M | — | — |
| 26 | AVIRAtea PharmaceuticalsHealthcare | $4.21 | $191.2M | $338.1M | — | — |
| 27 | CCCCC4 TherapeuticsHealthcare | $2.77 | $205.4M | $363.7M | −24.6% | — |
| 28 | KYTXKyverna TherapeuticsHealthcare | $5.03 | $174.4M | $311.1M | — | — |
| 29 | ATTOAttovia TherapeuticsHealthcare | $15.81 | $395.9M | $722.7M | — | — |
| 30 | NKTRNektar TherapeuticsHealthcare | $37.25 | $684.3M | $1.27B | −9.3% | — |
| 31 | KLRAKailera TherapeuticsHealthcare | $13.21 | $901.5M | $1.72B | — | — |
| 32 | FDMT4D Molecular TherapeuticsHealthcare | $12.12 | $341.7M | $669.3M | +25106.7% | — |
| 33 | CGEMCullinan TherapeuticsHealthcare | $10.19 | $334.5M | $661.5M | — | — |
| 34 | RLMDRelmada TherapeuticsHealthcare | $4.16 | $217.7M | $443.7M | — | — |
| 35 | RGNXREGENXBIOHealthcare | $8.03 | $251.0M | $531.0M | −69.2% | — |
| 36 | LTGOLatigo BiotherapeuticsHealthcare | $12.93 | $401.2M | $857.3M | — | — |
| 37 | LYELLyell ImmunopharmaHealthcare | $15.64 | $177.1M | $384.5M | −80.0% | — |
| 38 | JBIOJade BiosciencesHealthcare | $15.87 | $461.2M | $1.01B | — | — |
| 39 | DNAGinkgo Bioworks HoldingsHealthcare | $10.23 | $302.2M | $663.2M | −48.5% | — |
| 40 | KARDKardiganHealthcare | $14.12 | $597.6M | $1.32B | — | — |
| 41 | AVRAnteris Technologies GlobalHealthcare | $5.86 | $256.9M | $571.1M | +63.3% | — |
| 42 | SLDBSolid BiosciencesHealthcare | $7.00 | $348.9M | $781.3M | — | — |
| 43 | FLGTFulgent GeneticsHealthcare | $24.85 | $292.3M | $694.3M | +7.5% | — |
| 44 | CRSPCRISPR Therapeutics AGHealthcare | $42.62 | $1.69B | $4.13B | +1325.1% | — |
| 45 | VORVor BiopharmaHealthcare | $19.32 | $481.6M | $1.19B | — | 0.9× |
| 46 | EDITEditas MedicineHealthcare | $2.14 | $133.4M | $330.3M | +37.4% | — |
| 47 | AURAAura BiosciencesHealthcare | $7.11 | $297.2M | $740.0M | — | — |
| 48 | STTKShattuck LabsHealthcare | $4.81 | $196.3M | $489.9M | −100.0% | — |
| 49 | CAPRCapricor TherapeuticsHealthcare | $10.24 | $237.9M | $595.4M | — | — |
| 50 | DMRADamora TherapeuticsHealthcare | $22.05 | $528.5M | $1.36B | — | — |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.